Together, these data suggest that upregulation of GPT2 by PIK3CA mutations produces more α-KG from glutamine to replenish the TCA, thereby generating more ATP and intermediates for macromolecule synthesis to sustain rapid growth of PIK3CA mutant tumours. The gene discussed is GPT2; the disease is neoplasm.